Quick Answer
IMPACT BIOMEDICAL INC. reported Research And Development Expense of $340.0 thousand for the year ending 2025.
- IMPACT BIOMEDICAL INC. showed an increase of +22.3% in Research And Development Expense from 2024 to 2025.
- This data is from IMPACT BIOMEDICAL INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $206.0 thousand | Q3 2022: $330.0 thousand | Q1 2023: $179.0 thousand | Q2 2023: $266.0 thousand | Q3 2023: $357.0 thousand | Q1 2024: $183.0 thousand | Q2 2024: $121.0 thousand | Q3 2024: $82.0 thousand | Q1 2025: $103.0 thousand | Q2 2025: $75.0 thousand | Q3 2025: $52.0 thousand.
- Over the full 4 years of available data (2022 to 2025), IMPACT BIOMEDICAL INC.'s Research And Development Expense has declined by 72.3%.
- Historical annual values: Fiscal year 2025: $340.0 thousand | Fiscal year 2024: $278.0 thousand | Fiscal year 2023: $1.69 million | Fiscal year 2022: $1.23 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: